N-Acetylmuramic acid
|  | |
| Identifiers | |
|---|---|
| 10597-89-4  | |
| ChEBI | CHEBI:21615  | 
| ChemSpider | 4575341  | 
| Jmol 3D model | Interactive image | 
| PubChem | 5462244 | 
| 
 | |
| 
 | |
| Properties | |
| C11H19NO8 | |
| Molar mass | 293.27 g·mol−1 | 
| Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). | |
|  verify (what is   ?) | |
| Infobox references | |
N-Acetylmuramic acid, or MurNAc, is the ether of lactic acid and N-acetylglucosamine with a chemical formula of C11H19NO8. It is part of a biopolymer in the bacterial cell wall, built from alternating units of N-acetylglucosamine (GlcNAc) and N-acetylmuramic acid (MurNAc), cross-linked with oligopeptides at the lactic acid residue of MurNAc. This layered structure is called peptidoglycan.
MurNAc is a monosaccharide derivative of N-acetylglucosamine.
Clinical significance
N-Acetylmuramic acid (MURNAc) is part of the peptidoglycan polymer of Gram-positive bacterial cell walls. MURNAc is covalently linked to N-acetylglucosamine and may also be linked through the hydroxyl on carbon number 4 to the carbon of L-alanine (Figure 9.26). A pentapeptide composed of L-alanyl-d--isoglutaminyl-L-lysyl-D-alanine-D-alanine is added to the MURNAc in the process of making the peptidoglycan strands of the cell wall.
Synthesis is inhibited by fosfomycin.[1]
References
- ↑ Grif K, Dierich MP, Pfaller K, Miglioli PA, Allerberger F (August 2001). "In vitro activity of fosfomycin in combination with various antistaphylococcal substances". Journal of antimicrobial chemotherapy 48 (2): 209–17. doi:10.1093/jac/48.2.209. PMID 11481290.
See also
| 
 | ||||||||||||||||||||||||||||||||||||||